Sugi Predict

Sugi Predict / Compounds / SCHEMBL487568

SCHEMBL487568

SCHEMBL487568

NC(=O)C(O)[C@H](N)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.54
▸ LMNA P02545 4/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ EPHX1 P07099 1/20 0.46
▸ BCAT2 O15382 1/20 0.44
▸ ADRA2A P08913 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ SRC P12931 1/20 0.43
▸ F2 P00734 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CES2 O00748 1/20 0.42
▸ CES1 P23141 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL487361 1.00 DPP4 (0.54) DPP4LMNAMAPK1EPHX1BCAT2
SCHEMBL4744699 1.00 DPP4 (0.54) DPP4LMNAMAPK1EPHX1BCAT2
SCHEMBL487880 1.00 DPP4 (0.54) DPP4LMNAMAPK1EPHX1BCAT2
SCHEMBL4884477 1.00 DPP4 (0.54) DPP4LMNAMAPK1EPHX1BCAT2
SCHEMBL4887191 1.00 DPP4 (0.54) DPP4LMNAMAPK1EPHX1BCAT2
Hydrochloric Acid SCHEMBL487925 0.98 DPP4 (0.52) DPP4LMNAMAPK1EPHX1BCAT2
SCHEMBL939042 0.84 DPP4 (0.56) DPP4LMNAMAPK1ADRA2AADRA2C
SCHEMBL8058962 0.84 DPP4 (0.56) DPP4LMNAMAPK1ADRA2AADRA2C
SCHEMBL5860807 0.84 DPP4 (0.56) DPP4LMNAMAPK1ADRA2AADRA2C
SCHEMBL4073511 0.84 DPP4 (0.56) DPP4LMNAMAPK1ADRA2AADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663393-A CYCLIZATION; DECYCLIZATION; HYDROLYSIS; HYDROGENATION RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1997-09-02 — — US claimed
EP-0643626-A4 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL. RES CORP TECHNOLOGIES INC (US) 1995-12-06 — — EP claimed
EP-0643626-A1 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-03-22 — — EP claimed
WO-1993003838-A1 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-04 — — WO claimed
US-8106231-B2 Process for the preparation of (2R,3S)-3-phenylisoserine methyl ester acetate salt INDENA S.P.A. (IT) 2012-01-31 — — US disclosed
US-20100168460-A1 PROCESS FOR THE PREPARATION OF (2R,3S)-3-PHENYLISOSERINE METHYL ESTER ACETATE SALT INDENA S.P.A. (IT) 2010-07-01 — — US disclosed
EP-1961735-B1 Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt INDENA SPA (IT) 2009-11-18 — — EP disclosed
WO-2008101608-A1 PROCESS FOR THE PREPARATION OF (2R,3S)-3-PHENYLISOSERINE METHYL ESTER ACETATE SALT INDENA S.P.A. (IT) 2008-08-28 — — WO disclosed
EP-1961735-A1 Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt Indena S.P.A. (IT) 2008-08-27 — — EP disclosed
EP-0643626-B1 METHOD OF PRODUCING EPOXYCHROMANS WITH A CHIRAL CATALYST RES CORP TECHNOLOGIES INC (US) 2002-02-27 — — EP disclosed
US-5939561-A Process for the preparation of β-phenylisoserine and β-lactam and their analogues RHONE-POULENCE RORER S.A. (FR) 1999-08-17 — — US disclosed
EP-0804434-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES MERCK SHARP & DOHME LTD. (GB) 1997-11-05 — — EP disclosed
WO-1996004274-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1996-02-15 — — WO disclosed
EP-0643626-A4 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL. RES CORP TECHNOLOGIES INC (US) 1995-12-06 — — EP disclosed
EP-0643626-A1 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-03-22 — — EP disclosed
US-5359124-A Reacting benzylamine with cis-beta-phenylglycidic acid yields intermediate for anticarcinogenic taxol derivatives AVENTIS PHARMA S.A. (FR) 1994-10-25 — — US disclosed
EP-0515540-B1 DERIVATIVE OF BETA-PHENYLISOSERINE, PREPARATION AND UTILISATION THEREOF RHONE POULENC RORER SA (FR) 1994-07-06 — — EP disclosed
WO-1993003838-A1 CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-04 — — WO disclosed
EP-0515540-A1 DERIVATIVE OF BETA-PHENYLISOSERINE, PREPARATION AND UTILISATION THEREOF. RHONE POULENC RORER SA (FR) 1992-12-02 — — EP disclosed
WO-1991013053-A1 DERIVATIVE OF β-PHENYLISOSERINE, PREPARATION AND UTILISATION THEREOF RHONE-POULENC RORER S.A. (FR) 1991-09-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168460-A1 PROCESS FOR THE PREPARATION OF (2R,3S)-3-PHENYLISOSERINE METHYL ESTER ACETATE SALT SPTSSB, SRR, MTAP DPP4 3269/4885LMNA 3567/4885MAPK1 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.